Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
PONIF$0.12-0.00(-3.70%)Silver Pony Announces Closing of Up-Sized $1,600,015 Strategic Unit Offering[6:15:00 PM ET]ELME$0.07-1.70(-96.19%)Elme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026[5:47:00 PM ET]HHH$73.09+3.60(+5.18%)Howard Hughes Holdings Set to Join S&P SmallCap 600 Howard Hughes Holdings Inc. (NYSE: HHH) will replace Arcosa Inc. (NYSE: ACA) in the S&P SmallCap 600 effective prior to the opening of trading on...[5:45:00 PM ET]ALGRF$0.400.00(0.00%)Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita[5:30:00 PM ET]ZEFIF$0.45+0.02(+3.56%)Zefiro Announces Closing of Non-Brokered Private Placement for Gross Proceeds of Approximately C$5.0 Million[5:29:00 PM ET]BLK$1,118.50-18.79(-1.65%)BlackRock® Canada Announces the Termination of iShares Convertible Bond Index ETF[5:23:34 PM ET]ITFS$1.43-0.02(-1.10%)Itafos Announces Release Date for Q3 2026 Results and Business Update Webcast[5:15:00 PM ET]FAGI$0.01-0.00(-13.33%)Full Alliance Group, Inc (OTC:FAGI) YAHBEE Highlights Community-Commerce Model for Agentic Commerce Era[5:15:00 PM ET]TGT$152.76-5.35(-3.38%)Vital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Stores[5:05:00 PM ET]NU$15.23+0.50(+3.39%)Notice to Market: Nu Holdings Ltd.[5:03:00 PM ET]POR$44.55-0.35(-0.78%)Portland General Electric Declares Dividend[5:00:00 PM ET]ANTX$3.55-0.09(-2.47%)AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)[5:00:00 PM ET]

SNY · NASDAQ

Sanofi

$41.26 -0.72 (-1.72%)

Company overview

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines.

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Market cap
$99.9B
Employees
82,878
Headquarters
Paris
Website
sanofi.com
CEO
Olivier Charmeil
Listed
July 1, 2002
P/E
21.27
Dividend yield
5.58%

Company financials

Revenue
$47.4B
Gross profit
$34.2B
Operating income
$6.3B
EBITDA
$12.6B
Net income
$7.6B
EPS
$1.94
Total assets
$128B
Total debt
$20B
Gross margin
72.18%
Net margin
15.95%
Earnings yield
4.70%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

38.6941.2643.8446.4148.98
SNY 1D NASDAQ O41.17H42.11L41.07C41.96+0.99 (+2.42%)Vol3.46M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
SNY Stock news Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market The Motley Fool
SNY Press release Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System GlobeNewswire
SNY Press release Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany GlobeNewswire
SNY Press release Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany GlobeNewswire
SNY Stock news Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share The Motley Fool
SNY Stock news Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady 24/7 Wall Street
SNY Press release Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration GlobeNewswire
SNY Stock news Which Pharma Stock Looks More Attractive: Sanofi or AbbVie? Zacks Investment Research
SNY Press release AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test GlobeNewswire
SNY Stock news EU Accepts Sanofi's Concessions to Settle Antitrust Probe Over Vaccine Marketing WSJ
ACN Stock news 5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% Plus (October 2026) Seeking Alpha
MRNA Stock news Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026? The Motley Fool
SNY Press release Press Release : Availability of the aide-mémoire for Q3 2026 results GlobeNewsWire
SNY Stock news As First Dupixent MDL Hearing Opens, Weitz & Luxenberg Points to Sanofi's Own Words on a Cancer That Hides Behind Eczema Business Wire
SNY Stock news Sanofi, Regeneron Expand Immunology Alliance With New Antibodies Zacks Investment Research
SNY Stock news Regeneron And Sanofi Announce A Win-Win Collaboration Expansion Seeking Alpha
SNY Stock news Regeneron, Sanofi Expand Alliance in Deal Worth Up to $8 Billion MarketBeat
SNY Stock news Sanofi, Regeneron Expand DUPIXENT Alliance in Deal Worth Up to €8 Billion MarketBeat
SNY Stock news Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion WSJ
SNY Stock news Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal Reuters
See more
FAQ

Questions about Sanofi

What does Sanofi do?
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines.
What is SNY's market cap?
Sanofi (SNY) is a listed stock with a live quote. The latest market cap on this page is $99.9B.
Where is Sanofi headquartered?
Sanofi is headquartered in Paris.
How do I get SNY news from the API?
Call GET /v1/news?tickers=SNY. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does SNY news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SNY, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the SNY price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs